Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Glycoprotein – e.g. – mucins – proteoglycans – etc.
Reexamination Certificate
2005-07-19
2005-07-19
Canella, Karen A. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Glycoprotein, e.g., mucins, proteoglycans, etc.
C530S828000
Reexamination Certificate
active
06919435
ABSTRACT:
The monoclonal antibody produced by a hybridoma cell strain TRD-L1, -L2 or -L3 which is obtained by the fusion between mouse myeloma cells and spleen cells of a mouse immunized with a human lung adenocarcinoma cell secretion component reacts in a specific fashion with a glycoprotein antigen that has a moecular weight of 200 kD or more (SDS-PAGE) and is present in human lung adenocarcinoma cells. It can be used efficiently in cancer diagnosis.
REFERENCES:
patent: 5314996 (1994-05-01), Wright et al.
patent: 5422239 (1995-06-01), Wands et al.
patent: 5650333 (1997-07-01), Holtlund et al.
patent: 5888773 (1999-03-01), Jost et al.
patent: 0232871 (1987-08-01), None
patent: 63-19561 (1988-01-01), None
patent: 63-222700 (1988-09-01), None
patent: 2-72198 (1990-03-01), None
Stedman's Medical Dictionary (27 Edition 2000).
Stein and Goldenberg, “A murine monoclonal antibody raised against human non-small cell carcinoma of the lung”, Hybridoma, 1988, vol. 7, pp. 555-567.
Gorbachev et al, “A biochemical study of antigen A2F4 assoicated with human lung adenocarcinoma”, Biokhimiya, 1994, vol. 59, pp. 1401-1405 (abstract only).
DeRobertis and DeRobertis, Cell and Mlecular Bology (textbook), 7th Ed., 1975, pp. 235-237.
Kate et al, “Adenosine Deaminase Complexing Protien in Cancer Studies”, Anticancer Research, vol. 6, pp. 983-988, 1986.
Eskelinen et al, “Clinical Value of Serum Tumor Markers TPA, TPS, TAG 12 . . . ”, Anticancer Research, vol. 14, pp. 699-704, 1994.
Maimonis, Peter, et al., “Detection and Characterization of a High Molecular Weight Human Lung Carcinoma-associated Glycoprotein.”Cancer Research50, Oct. 15, 1990, pp. 6738-6743.
Tsuji, K., et al, “Detection of the Circulating Lung Cancer Marker LCAP with a New Monoclonal Antibody TRD-L1”, International Journal of Biological Markers, vol. 12, No. 2, 1997, pp. 49-54, XP-000906791.
Werner, M., et al, “Immunohistochemical and Biochemical Characterization of the Mucin-Type Tumor Associated Antigen TAG-12 by Monoclonal Antibody 7A9”, Pathology, Research and Practice, vol. 187, No. 7, Sep. 1991, pp. 864-870, XP-000906786.
Yang, Pan-Chyr, “Characterization of the Mucin Differentiation in Human Lung Adenocarcinoma Cell Lines”, American Journal of Respiratory Cell and Molecular Biology, vol. 7, 1992, pp. 161-171, XP-000906796.
Tsuji Kouichi
Uwano Takashi
Yoshida Yoshihiro
Burns Doane Swecker & Mathis L.L.P.
Canella Karen A.
Fujirebio Inc.
LandOfFree
Human lung adenocarcinoma-related monoclonal antibody and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human lung adenocarcinoma-related monoclonal antibody and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human lung adenocarcinoma-related monoclonal antibody and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3383061